The Union: Submissions Open for Late-Breaker Sessions on TB, COVID-19 and Lung Health until 12 August 2021
The 52nd Union World Conference on Lung Health is pleased to announce that submissions for Late-Breaker Sessions are open from 15 July-12 August 2021. Submit now!
In keeping with the spirit of a late-breaker session, we ask that only new, innovative and significant findings of broad interest that have occurred after 12 May, or for which information has just become available, be submitted for the late-breaker sessions.
The following three late-breaker sessions are slated for the Conference that will take place from 19-22 October 2021:
THE UNION LATE-BREAKER SESSION ON COVID-19
All aspects of SARS-CoV-2 and Covid-19-related lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, clinical trials for vaccines or therapeutics, to operational research in adults and children.
This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with the online audience.
THE UNION/CDC LATE-BREAKER SESSION ON TB
The 52nd Union World Conference on Lung Health and the United States Centers for Disease Control and Prevention (CDC) are pleased to announce a late-breaker session related to tuberculosis (TB).
This late-breaker session includes all aspects of TB prevention, diagnosis, and treatment research (including basic and clinical science, epidemiology, social, behavioural, and health care delivery). Given the global COVID-19 pandemic, we will also consider select presentations that explore the intersection of COVID-19 and TB prevention and programmatic implementation. It will consist of 7 pre-recorded oral presentations of 8 minutes each and live Q&A at the end of the session. The session is scheduled on 22 October 2021.
THE UNION STUDENT LATE-BREAKER SESSION ON LUNG HEALTH
The 52nd Union World Conference on Lung Health is pleased to announce the Union student late-breaker session focusing on lung health and sponsored by the Research Institute of Tuberculosis of the Japan Anti-Tuberculosis Association (RIT/JATA).
All aspects of lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, to operational research in tuberculosis (TB), Chronic Obstructive Pulmonary Disease (COPD), pneumonia, and other lung health issues in adults and children. This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with online audience.
Individuals submitting an abstract must be currently enrolled as a student in a university programme at undergraduate, graduate, or doctoral level either full- or part-time.
DETAILS
All abstracts must follow the abstract submission guidelines
For more information and details on sponsorship for late-breaker sessions: https://theunion.org/late-breaker-sessions
For any further queries, email scientific@theunion.org
Articles
13Th Edition Of The Edctp Forum To Take Place In Madrid, Spain, From 5 To 9 April 2027
We are delighted to announce that the 13th edition of the EDCTP Forum will be celebrated on 5-9 April 2027, at IFEMA Palacio Municipal in Madrid, Spain.
The event will be co-hosted by the Instituto de Salud Carlos III (ISCIII) under the Spanish Ministry of Science, Innovation and Universities and the Fundación CSAI (FCSAI) under the Ministry of Health, and is co-organised by Global Health EDCTP3 and the EDCTP Association.
Over the past two decades, the biennial European & Developing Countries Clinical Trials Partnership (EDCTP) Forum has evolved to become a cornerstone event for global health research, bringing together leading voices advancing the fight against infectious diseases in sub-Saharan Africa. It showcases the latest scientific breakthroughs, highlights impactful capacity-building efforts, and creates a space for vibrant cross-regional collaboration.
The EDCTP Forum 2027 expects to convene 1,500 participants and stakeholders, from researchers, universities and clinicians to governments, regional bodies, civil society, regulators, and public and private R&D partners, drawing participation primarily from Africa and Europe.
Dr Tuelo Mogashoa Becomes First Tagendi Phd Graduate
Botswana-born scientist Dr Tuelo Mogashoa, a PhD Fellow in the ‘Addressing Gender and Diversity Regional Gaps in Clinical Research Capacity’ (TAGENDI) programme, has successfully defended her PhD in Molecular Biology (Tuberculosis Genomics) at Stellenbosch University. Her virtual oral examination, held on 12 January 2025, marked the culmination of years of research and training.
Her doctoral thesis, titled “Rifampicin- resistant tuberculosis: an emerging threat to human health in Botswana,” addresses one of the most pressing challenges in TB control.
Dr Mogashoa is the first of seven PhD fellows from the inaugural TAGENDI cohort to complete her doctoral studies. The TAGENDI fellowship, implemented under the Trials of Excellence in Southern Africa (TESA) Network, is part of a dedicated PhD fellowship scheme launched by EDCTP2 in 2020 to support women in health research across sub-Saharan Africa. Coordinated by the EDCTP Networks of Excellence, the initiative received funding from the UK National Institute for Health and Care Research (Department of Health and Social Care).
As part of her PhD requirements, Dr Mogashoa was expected to produce four manuscripts, with at least two accepted in peer-reviewed journals. She has exceeded this requirement, publishing three peer-reviewed articles from her doctoral work, with a fourth manuscript currently under review.
Her journey highlights the transformative impact of long-term investment in research training, mentorship, and gender equity. As she moves into the next phase of her career, her work promises to make a meaningful contribution to improving TB diagnosis, treatment, and control.
More information:
- Dr Tuelo Mogashoa Successfully Defends PhD in TB Genomics
- Tuelo’s journey: building Botswana’s capacity for cutting-edge health research
Prof. Novel Chegou Elected As Fellow Of The African Academy Of Sciences
Prof. Novel Chegou, EDCTP Senior Fellow and Acting Head of the Division of Immunology at the Faculty of Medicine and Health Sciences, Stellenbosch University, has been elected as a Fellow of the African Academy of Sciences. This important achievement recognises his scientific leadership and impactful research on tuberculosis, particularly his work on biomarkers to improve diagnosis and patient care in resource-limited settings.
Read more